A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients ...

For decades, the diagnosis of multiple myeloma required evidence of end-organ damage characterized by myeloma-defining events ...

While there is no cure for multiple myeloma, increased awareness about the symptoms can be the key to timely diagnosis and ...

Hematologist-oncologist Mateo Mejia Saldarriaga, MD, combines clinical care with research aimed at helping patients with ...

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...

每年3月是国际骨髓瘤关爱月，旨在呼吁公众关注多发性骨髓瘤（Multiple myeloma，MM）这一血液系统恶性肿瘤。据统计，我国多发性骨髓瘤发病率逐年上升，且患者平均年龄较西方国家更低（约57岁），骨痛、贫血、肾功能损害等症状严重影响生活质量。3月26日记者从广州中医药大学第三附属医院血液肿瘤科了解到多发性骨髓瘤相关科普内容。

CAR-T therapy for myeloma faces challenges in early-line use due to accessibility, eligibility criteria and long wait times, ...

Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.

This is Allison’s personal multiple myeloma story, and others may be different. Allison is a paid spokesperson for GSK.

More than half of patients recently diagnosed with lymphoma or myeloma had clinically significant symptoms of anxiety or ...

The addition of subcutaneous daratumumab to triplet therapy improved outcomes for certain patients with newly diagnosed ...

The following is a summary of “BCMA CAR-T therapy as salvage therapy in patients with plasmablastic myeloma,” published in ...